All In Biotech

Drug Trial Radar · NCT00870298

Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin

Randomized Controlled Study of a Computer Stop Order Versus Routine Practice When Trimethoprim/Sulfamethoxazole is Ordered Concurrently With Warfarin

Last checked: Nov 19, 2026Latest source record: Dec 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 1,971 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,971

Actual

Start

Aug 2006

Primary completion

Jan 2007

Study completion Jan 2007

Sponsor

Lead sponsor
University of PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 27, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.

Conditions

  • Prescribers' Drug Orders

Interventions

  • Trimethoprim/Sulfamethoxazole and WarfarinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduce concomitant orders for warfarin and tmp/smxTime frame: 7 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.